Atossa Therapeutics (ATOS) Assets (2011 - 2026)
Atossa Therapeutics (ATOS) recorded Assets of $32.28 million in Q2 2026, down 50.0% from $64.52 million a year earlier and down 14.9% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Atossa Therapeutics reported Assets of $47.61 million, down 37.7% from FY2024.
- Annual Assets has declined for four straight years, though with a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- Across earlier years, Assets came in at $76.44 million in FY2024 (-20.6%), $96.25 million in FY2023 (-22.1%), $123.53 million in FY2022 (-12.6%) and $141.26 million in FY2021 (+229.8%).
- The Q2 2026 figure is the lowest quarterly Assets since Q3 2020.
- On a year-over-year basis, Assets has declined for 18 consecutive quarters, with an average decline of 31.3% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 229.8% in Q4 2021, against a decline of 50.0% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $37.94 million (Q1 2026), $47.61 million (Q4 2025) and $58.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | 32.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.28 Mn |
| Mar 31, 2026 | 37.94 Mn |
| Dec 31, 2025 | 47.61 Mn |
| Sep 30, 2025 | 58.01 Mn |
| Jun 30, 2025 | 64.52 Mn |
| Mar 31, 2025 | 70.75 Mn |
| Dec 31, 2024 | 76.44 Mn |
| Sep 30, 2024 | 79.48 Mn |
| Jun 30, 2024 | 85.86 Mn |
| Mar 31, 2024 | 91.09 Mn |
| Dec 31, 2023 | 96.25 Mn |
| Sep 30, 2023 | 101.70 Mn |
| Jun 30, 2023 | 108.36 Mn |
| Mar 31, 2023 | 116.20 Mn |
| Dec 31, 2022 | 123.53 Mn |
| Sep 30, 2022 | 126.72 Mn |
| Jun 30, 2022 | 134.05 Mn |
| Mar 31, 2022 | 137.48 Mn |
| Dec 31, 2021 | 141.26 Mn |
| Sep 30, 2021 | 143.02 Mn |
API Access
Atossa Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();